BioBeat23: Out of adversity comes opportunity

The meeting will explore the challenges and opportunities for biotechs of fundraising in the current economic downturn. The fantastic speakers will look at the realities of how deals get done and the emerging opportunity hot-spots. Come and join the conversations!

BioBeat23: Out of adversity comes opportunity.  Supported by: Appleyard Lees, bit.bio, Covington, Entrepreneurship Centre Cambridge Judge Business School, Innovation Forum, Martlet, One Nucleus

13.30 - 14.00 Registration

14.00-14.10 Wellcomes

14.10-15.10 Panel: Fundraising in an economic downturn

Carolyn Porter, CEO, CystoSeek (Chair), Hannah Sore, CEO, PharmEnable, Jia Yi Har, Partner, Cathay Capital, Olivia Cavlan, Chief Corporate Development and Strategy Officer, Alchemab Therapeutics

15.10-15.40 Tea

15.40-16.40 Panel: Emerging opportunity hot-spots

Alisa Molotova, Investment Manager, Martlet Capital, Barbara Domayne-Hayman, Entrepreneur in Residence, The Francis Crick Institute (Chair), Christine Martin, Head of Seed Funds, Cambridge Enterprise, Oriane Chausiaux, CSO, Heartfelt Technologies, Ruchi Sharma, CEO, Stemnovate

16.40-16.45 Wrap-up and thanks

16.45-18.15 Drinks and canapes

Looking for something specific?